A prime opportunity for pharma to raise its strategic game in ESG.
Jen Nixon
Advertisement
Articles by Jen Nixon
The pharma industry is beginning to perform better with environmental, social, and governance (ESG).
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly to Submit Oral GLP-1 for FDA Priority Review Program: Report
2
GCC Emerges as a New Strategic Anchor for Global Venture Capital
3
Tylenol Maker Sued While Kennedy Says No ‘Sufficient’ Evidence for Autism Link
4
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
5
